Author: Schulman C.
Publisher: Elsevier
ISSN: 1569-9056
Source: European Urology Supplements, Vol.2, Iss.3, 2003-03, pp. : 20-27
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Role of Endothelin in Hormone-Refractory Prostate Cancer
European Urology Supplements, Vol. 2, Iss. 3, 2003-03 ,pp. :
Endothelin and Skeletal Metastases in Hormone-Refractory Prostate Cancer
By Hamdy F.C.
European Urology Supplements, Vol. 2, Iss. 3, 2003-03 ,pp. :
Revolutions in the Management of Hormone-Refractory Prostate Cancer
European Urology Supplements, Vol. 2, Iss. 3, 2003-03 ,pp. :
The Role of Urologists in the Management of Hormone-Refractory Prostate Cancer
By Pummer K.
European Urology Supplements, Vol. 1, Iss. 2, 2002-05 ,pp. :
Chemotherapy for the Treatment of Hormone-Refractory Prostate Cancer
European Urology Supplements, Vol. 1, Iss. 2, 2002-05 ,pp. :